AccessCR Pty Ltd’s mission is to improve the quality, efficiency and experience of clinical trials, such that the hope of new care and treatment options for patients is realised as quickly as possible. AccessCR provides consultancy, contract support and services to clinical trial sponsors, research sites and other organisations to improve research conduct and increase awareness of, access to, participation in, the experience of and consumer involvement in clinical research and therapeutics development. Our commitment to patients and their families extends to actively advocating to address the consumer needs around research and supporting inclusion of their voice in research.
AccessCR closed on the 30 Jun 2026, though its founder, Janelle Bowden, remains passionate about clinical trials, therapeutic development, and the patient experience and involvement in them.